Upgrade to SI Premium - Free Trial

Stoke Therapeutics Inc. (STOK)

30.01 -0.11 (0.37%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/10/26)

Latest Headlines

Form 8-K Stoke Therapeutics, Inc. For: Jun 03 June 4, 2026 4:08 PM - SEC Filing Form 4 Stoke Therapeutics, Inc. For: Jun 01 Filed by: Ticho Barry June 3, 2026 5:34 PM - SEC Filing Stoke Therapeutics to Present at Upcoming Investor Conferences in June May 28, 2026 4:01 PM - BizWire Form SCHEDULE 13G/A Stoke Therapeutics, Inc. Filed by: Lynx1 Capital Management LP May 18, 2026 9:30 PM - SEC Filing Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) May 18, 2026 4:01 PM - BizWire Form SCHEDULE 13G/A Stoke Therapeutics, Inc. Filed by: Lynx1 Capital Management LP May 15, 2026 4:36 PM - SEC Filing Form SCHEDULE 13G/A Stoke Therapeutics, Inc. Filed by: Redmile Group, LLC May 15, 2026 4:25 PM - SEC Filing Form SCHEDULE 13G/A Stoke Therapeutics, Inc. Filed by: TORONTO DOMINION BANK May 15, 2026 1:47 PM - SEC Filing Form SCHEDULE 13G/A Stoke Therapeutics, Inc. Filed by: RTW INVESTMENTS, LP May 15, 2026 8:32 AM - SEC Filing Form SCHEDULE 13G Stoke Therapeutics, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP May 15, 2026 7:06 AM - SEC Filing Form 8-K Stoke Therapeutics, Inc. For: May 07 May 7, 2026 4:23 PM - SEC Filing Stoke Therapeutics, Inc. (STOK) Tops Q1 EPS by 2c May 7, 2026 4:15 PM - StreetInsider Form 10-Q Stoke Therapeutics, Inc. For: Mar 31 May 7, 2026 4:08 PM - SEC Filing Stoke Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Updates May 7, 2026 4:01 PM - BizWire Form 4 Stoke Therapeutics, Inc. For: May 01 Filed by: Ticho Barry May 5, 2026 4:19 PM - SEC Filing Form 144 Stoke Therapeutics, Inc. Filed by: Ticho Barry May 1, 2026 4:44 PM - SEC Filing Stoke Therapeutics to Host Webcast and Conference Call to Discuss First Quarter 2026 Business and Financial Updates April 30, 2026 4:01 PM - BizWire Form ARS Stoke Therapeutics, Inc. For: Dec 31 April 22, 2026 4:13 PM - SEC Filing Form DEFA14A Stoke Therapeutics, Inc. April 22, 2026 4:10 PM - SEC Filing Form DEF 14A Stoke Therapeutics, Inc. For: Jun 03 April 22, 2026 4:06 PM - SEC Filing Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) April 16, 2026 4:01 PM - BizWire Zealand Pharma names Eric Rojas as VP of investor relations April 14, 2026 10:01 AM - StreetInsider Zealand Pharma names Eric Rojas as VP of investor relations April 14, 2026 10:00 AM - StreetInsider Stoke Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference April 8, 2026 4:01 PM - BizWire The Credibility Filter Wall Street Uses to Sort Biotech Winners April 8, 2026 9:15 AM - StreetInsider Form 4 Stoke Therapeutics, Inc. For: Apr 03 Filed by: Kahn Clare April 7, 2026 7:09 PM - SEC Filing Form 3 Stoke Therapeutics, Inc. For: Apr 03 Filed by: Kahn Clare April 7, 2026 7:08 PM - SEC Filing Form 8-K Stoke Therapeutics, Inc. For: Apr 03 April 7, 2026 4:07 PM - SEC Filing Stoke Therapeutics adds Clare Kahn to board of directors April 7, 2026 4:01 PM - StreetInsider Stoke Therapeutics Appoints Clare Kahn, Ph.D., to its Board of Directors April 7, 2026 4:01 PM - BizWire Form 4 Stoke Therapeutics, Inc. For: Apr 01 Filed by: Ticho Barry April 3, 2026 4:13 PM - SEC Filing Form 144 Stoke Therapeutics, Inc. Filed by: Ticho Barry April 1, 2026 4:40 PM - SEC Filing Form 8-K Stoke Therapeutics, Inc. For: Mar 23 March 27, 2026 4:31 PM - SEC Filing Form SCHEDULE 13G/A Stoke Therapeutics, Inc. Filed by: VANGUARD GROUP INC March 27, 2026 1:18 PM - SEC Filing Form 4 Stoke Therapeutics, Inc. For: Mar 20 Filed by: Allan Jonathan March 24, 2026 4:20 PM - SEC Filing Form 144 Stoke Therapeutics, Inc. Filed by: Allan Jonathan March 20, 2026 4:34 PM - SEC Filing Stoke Therapeutics (STOK) PT Raised to $60 at Canaccord March 20, 2026 6:56 AM - StreetInsider Form 4 Stoke Therapeutics, Inc. For: Mar 17 Filed by: Ticho Barry March 19, 2026 6:02 PM - SEC Filing Form 4 Stoke Therapeutics, Inc. For: Mar 17 Filed by: Leggett Thomas March 19, 2026 6:01 PM - SEC Filing Form 4 Stoke Therapeutics, Inc. For: Mar 17 Filed by: Hoitt Jason March 19, 2026 5:59 PM - SEC Filing Form 4 Stoke Therapeutics, Inc. For: Mar 17 Filed by: Allan Jonathan March 19, 2026 5:57 PM - SEC Filing Form 144 Stoke Therapeutics, Inc. Filed by: Ticho Barry March 19, 2026 4:21 PM - SEC Filing Stoke Therapeutics Inc. (STOK) files mixed shelf March 18, 2026 4:09 PM - StreetInsider Form S-3ASR Stoke Therapeutics, Inc. March 18, 2026 4:07 PM - SEC Filing Stoke Therapeutics (STOK) PT Raised to $38 at Wedbush March 18, 2026 7:45 AM - StreetInsider Form 4 Stoke Therapeutics, Inc. For: Mar 15 Filed by: Hoitt Jason March 17, 2026 5:27 PM - SEC Filing Form 4 Stoke Therapeutics, Inc. For: Mar 15 Filed by: Leggett Thomas March 17, 2026 5:26 PM - SEC Filing Form 4 Stoke Therapeutics, Inc. For: Mar 15 Filed by: Ticho Barry March 17, 2026 5:25 PM - SEC Filing Form 4 Stoke Therapeutics, Inc. For: Mar 15 Filed by: Kaye Edward M. MD March 17, 2026 5:24 PM - SEC Filing Form 4 Stoke Therapeutics, Inc. For: Mar 15 Filed by: Allan Jonathan March 17, 2026 5:24 PM - SEC Filing Form 4 Stoke Therapeutics, Inc. For: Mar 13 Filed by: LEVIN ARTHUR A March 17, 2026 5:23 PM - SEC Filing Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) March 17, 2026 5:12 PM - BizWire Stoke Therapeutics (STOK) PT Raised to $40 at Needham March 17, 2026 7:06 AM - StreetInsider Form S-8 Stoke Therapeutics, Inc. March 16, 2026 5:29 PM - SEC Filing Form 10-K Stoke Therapeutics, Inc. For: Dec 31 March 16, 2026 4:16 PM - SEC Filing Form 144 Stoke Therapeutics, Inc. Filed by: LEVIN ARTHUR A March 13, 2026 4:20 PM - SEC Filing Form 4 Stoke Therapeutics, Inc. For: Mar 10 Filed by: TZIANABOS ARTHUR March 12, 2026 4:58 PM - SEC Filing Form 4 Stoke Therapeutics, Inc. For: Mar 10 Filed by: Krainer Adrian R. March 12, 2026 4:56 PM - SEC Filing Form 144 Stoke Therapeutics, Inc. Filed by: TZIANABOS ARTHUR March 10, 2026 4:40 PM - SEC Filing Full Article List